As drug discovery continues to explore more human-relevant approaches to disease modeling, human iPSC technology is gaining momentum. Using this technology, consented blood or skin donations from patients and healthy donors are ‘reprogrammed’ into a stem cell state, from which they can be turned into any cell type including neurons, neuroinflammatory cells, muscle cells and … Continue reading Better in vitro models with human iPSC-derived cells